Business
AstraZeneca and Johnson & Johnson given green light to resume US coronavirus vaccine trials – ABC News
In a sign of progress in the race to develop a vaccine for COVID-19, AstraZeneca’s resumption of its US clinical trial is set to be soon followed by Johnson & Johnson…
AstraZeneca has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week.
Key points:
- Both vaccine candidates had been forced to pause US trials after participant illnesses
- But both have been cleared to resume after it was found the vaccines were not the cause
- The race for a vaccine comes as coronavirus infections rise in dozens of countries
The news signalled progress against the novel coronavirus…
Continue Reading
-
Noosa News10 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News11 hours agoMotorcyclist dies in crash with truck
-
Noosa News11 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General16 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging